LIFE + is trading at 6.40 as of the 29th of November 2024. This is a 0.79 percent up since the beginning of the trading day. The stock's lowest day price was 6.35. LIFE + has 50 percent odds of going through some form of financial distress in the next two years but had a very good returns during the last 90 days. Equity ratings for LIFE BANC SPLIT are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of September 2024 and ending today, the 29th of November 2024. Click here to learn more.
Life Banc Split Corp. is a closed-ended equity mutual fund launched and managed by Brompton Funds Limited. Life Banc Split Corp. was formed on September 6, 2006 and is domiciled in Canada. LIFE BANC is traded on Frankfurt Stock Exchange in Germany. More on LIFE BANC SPLIT
Although LIFE +'s alpha and beta are two of the key measurements used to evaluate LIFE +'s performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in LIFE + without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Stock Screener Now
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
LIFE + financial ratios help investors to determine whether LIFE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LIFE with respect to the benefits of owning LIFE + security.